Optimal synthesis of biocompatible bovine serum nanoparticles- incorporated quercetin (BSA NPS-QT) nano drug conjugate for the controlled release and improved anti oxidative activity

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 5, Issue 3, 2014, Pages 478-487

  Karthick Raja Namasivayam, S ^a   Anand Raj, L F A ^c   George Robin, A T ^a   Helan Chandra, J ^b   Arvind Bharani, R S ^a  

^a SATHYABAMA UNIVERSITY   (India)

^b JEPPIAAR ENGINEERING COLLEGE   (India)

^c ST JOSEPH S COLLEGE OF ENGINEERING   (India)

Author keywords

Antioxidant drug delivery; BSA; Coacervation; Controlled release; Nanoparticles; Quercetin

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ASCORBIC ACID; BOVINE SERUM ALBUMIN; GLUTARALDEHYDE; NANOCONJUGATE; NANOPARTICLE; QUERCETIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; COACERVATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PH; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; TEMPERATURE;

EID: 84901237148     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dreis S, Rothweiler F, Michaelis M, Cinatl J, Kreuter J, Langer K. Int J Pharm 2007; 3: 201-207.
2. Azarmi H, Huang Y, Chen S, Quarrie MD, Abrams W, Roa WH, Finlay G, Miller G, Löbenberg R. J Pharm Pharm Sci 2006; 9; 124-127.
3. Arangoa M, Campanero A, Renedo J, Ponchel G, Irache J. Pharm Res 2001; 18: 1521-1531.
4. Bouchemal K, Briançon S, Perrier E, Fessi H. Int J. Pharm 2009; 28: 241-247.
5. Amzallag A, Jacob M, Unser Bednar M, Kahn J, Dubochet A, Stasiak J, Maddocks H. Nucleic Acids Res 2006; 34: 125-131.
6. Jahanshahi M, Sanati MH, Hajizadeh S, Babaei Z. Physica Status Solidi (A). 2008; 5: 10-15.
7. Kreuter Ramge J, Petrov P, Hamm S, Gelperina SE, Engelhardt R, Lyautdin H, Von Briesen V, Begley D. Pharm Res 2003; 20: 416-419.
8. Dunn M, Corrigan O Ramtoola Z. Biomater 2000; 21: 1659.
9. Edith M, et al. Nature 1997; 386: 410-412.
10. Kumaresh S, Tejraj A, Anandrao K, Walter A. J Control Rel 2001; 70: 1-11.
11. Weber C, Coester C, Kreuter J, Langer K. Int J Pharm 2000; 194: 91-93.
12. Wilson P. Cytotoxicity and Viability Assays in Animal Cell Culture: A Practical Approach. 2008; 121: 42-47.
13. Kreuter J. Adv Drug Del Rev 1991; 7: 71-73.
14. Couvreur P, Gref R, Andrieux K, Malvy C. Prog Solid State Chem 2006; 34: 231-237.
15. Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P. J Pharm Pharmacol 1979; 71: 331-334.
16. Kreuter J. Pharm Acta Helv 1983; 58: 196-198.
17. Stella B, Arpicco Rocco S, Marsaud V, Renoir J, Cattel L. Int J Pharm 2007; 344: 71-77.
18. Lin W, Coombes A, Davies M, Davis S, Illum L. J Drug Target 1993; 1: 237-239.
19. Jameela R, Jayakrishnan A. Biomater 1995; 16: 769-771.
20. Scheffel U, Rhodes A, Natarajan K, Wagner H. J Nucl Med 1972; 13: 498-500.
21. Schafer V, Von Briesen H, Andreesen R, Steffan M, Royer C, Troster S, Kreuter J, Rubsamen H. Pharm Res 1992; 9: 541-543.
22. Narayani R, Rao P. Int J Pharm 1993; 12: 85-89.
23. Mua L & Seowc PH. Colloids Surf B 2006; 47: 81-84.
24. Emile C, Bazile D, Herman F, Helene C, Veillard M. Drug Deliv 1996; 3: 187-190.
25. Rubino P, Kowalsky R, Swarbrick J. Pharm Res 1993; 10: 1059-1061.
26. Karthick Raja Namasivayam S, George Robin. Asian J Pharm Clin Res 2013; 6: 235-239.
27. Lin W, Garnett C, Davies C, Bignotti F, Ferruti P, Davis S, Illum L. Biomater 1997; 18: 559-561.
28. Majumdar S, Basu K. Antimicrob Agents Chemother 1991; 35: 135-139.
29. Karthick Raja Namasivayam S, Ghanadra Kumar E, Reepika R. Nano Micro Letter 2010; 6: 112-119.
30. Takka S, Rajbhandari S, Sakr A. Eur J Pharm Biopharm 2001; 52: 75-79.
31. Gelderblom H, Verweij J, Nooter K, Sparreboom A, Cremophor L. Eur J Cancer 2001; 37: 1590-1593.
32. Gradishar J, julandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, Shaughnessy J. J Clin Oncol 2005; 23: 7794-7798.